WA
HBIO icon

Whitebox Advisors’s Harvard Bioscience HBIO Stock Holding History

Whitebox Advisors’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,974
Closed -$231K – 368
2015
Q1 		$231K Buy
+3,974
New +$213K 0.01% 326

Other funds holding HBIO

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Whitebox Advisors's HBIO Position: Q2 2015 in Review

Whitebox Advisors sold out of Harvard Bioscience (HBIO) in Q2 2015, closing a stake of 3,974 shares — an estimated $231K sold.

Whitebox Advisors first reported a position in HBIO in Q1 2015 and held it in 1 quarter. The position peaked at $231K in Q1 2015. 84 funds tracked by Wall St. Rank hold HBIO as of Q2 2015.

  • Whitebox Advisors reported no remaining Harvard Bioscience position as of Q2 2015 after selling out during the quarter.
  • Whitebox Advisors sold 3,974 Harvard Bioscience shares in Q2 2015, an estimated $231K.
  • Whitebox Advisors first reported a position in Harvard Bioscience in Q1 2015 and held it in 1 quarter.
  • Whitebox Advisors's Harvard Bioscience position peaked at $231K in Q1 2015.
  • 84 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2015.

Based on Whitebox Advisors's 13F filing for Q2 2015, filed 6 Aug 2015.